Answers are grounded in this paper and cite their sources.
INTRODUCTION: Metallic orbital foreign bodies may pose a safety risk during magnetic resonance imaging due to potential displacement or heating of ferromagnetic material within the magnetic field, potentially resulting in severe ocular injury. When their presence cannot be reliably excluded based on patient history, imaging is performed as a precautionary screening step prior to magnetic resonance imaging (MRI). Digital radiography (DR) is commonly used for this purpose due to its low radiation dose but provides limited anatomical and spatial information. Photon-counting CT (PCCT) offers high spatial resolution and improved dose efficiency and may serve as an alternative ultra-low-dose screening technique. This phantom study compared radiation exposure between DR and ultra-low-dose PCCT for orbital imaging. METHODS: Orbital imaging was performed in an Alderson RANDO phantom using DR and PCCT. Absorbed radiation doses to the eye lens and globe were measured using optically stimulated luminescence dosimeters (OSLDs) and effective doses were estimated from standard dose descriptors and compared for both modalities. RESULTS: Mean absorbed doses of PCCT imaging were 0.092 mGy for the lens and 0.087 mGy for the globe, compared with 6.215 mGy and 4.855 mGy for DR, corresponding to dose reductions of 98.5% and 98.2%. Effective doses were 0.002 mSv for PCCT and 0.023 mSv for DR, corresponding to a 91.3% reduction. CONCLUSION: Ultra-low-dose PCCT substantially reduced ocular radiation exposure compared with DR while allowing visualization of the tested metallic foreign body. Further studies are warranted to evaluate its diagnostic performance as a dose-saving alternative for orbital foreign body screening prior to MRI. IMPLICATION FOR PRACTICE: Ultra-low-dose PCCT may represent a dose-saving alternative for orbital foreign body imaging prior to MRI, with the additional benefit of cross-sectional visualization. Further validation of diagnostic performance is required before routine clinical implementation.
No takes yet. Share an insight, caveat, or question.
Vogt et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: